Hodgkins Lymphoma

Hodgkins Lymphoma Specialists 

David Hodgson, MD, MPH, FRCPC

Associate Professor, Department of Radiation Oncology
University of Toronto
Staff Radiation Oncologist
Princess Margaret Hospital/ University Health Network 

Dr. Hodgson is an internationally recognized pediatric radiation oncologist who has made significant clinical and research contributions through his role at SickKids and his work at Princess Margaret Cancer Centre where he is the Site Group Lead for Pediatrics in the Department of Radiation Oncology and the Director of POGO’s Adult Pediatric AfterCare Clinic.  He is a Professor in the Departments of Radiation Oncology, and Health Policy Management and Evaluation at the University of Toronto. He serves as Vice-chair of the Children’s Oncology Group (COG) Hodgkin Lymphoma Steering Committee and as a member of the Childhood Cancer Survivorship (CCSS) External Advisory Board. He has a stellar and long-standing track record in health services research and is cross-appointed to the Institute for Clinical Evaluative Sciences (ICES), having previously served as Associate Director of Clinical Epidemiology and Health Care Research at the Institute of Health Policy, Management and Evaluation (HPME). Dr. Hodgson comes to the POGO leadership position with a major clinical interest in lymphoma, in particular Hodgkin lymphoma, and in the late effects of cancer and the treatment of pediatric cancer survivors.


Kenneth Roberts, MD

Professor of Therapeutic Radiology
Director, Pediatric Radiothearpy Program

Yale School of Medicine
Associate Chief and Medical Director for Radiation Oncology
Shoreline Medical Center, Yale-New Haven Hospital  

As a practicing, productive academic physician, Dr. Robert's current clinical interests have emphasized the role of radiotherapy in pediatric malignancies, lymphomas, leukemias, sarcomas, colo-anal cancers, and benign inflammatory conditions. Correspondingly, his clinical research interests have been translational and practical, emphasizing combined modality therapy in cancer management, late effects of therapy including secondary malignancies, and the utilization of brachytherapy (implanted radiation sources) in both malignant and benign disease. 

Louis Constine, MD

Philip Rubin Professorship in Radiation Oncology 
Profesor Radiation Oncology

University of Rochester School of Medicine

As a radiation oncologist, vice chair of UR Medicine's Department of Radiation Oncology, and Director of Wilmot Cancer Institute's Judy DiMarzo Cancer Survivorship Program, my professional life is guided by, in my own words: "For the survivor of cancer, the world is full and each day is a celebration; For the physician, each patient is an inspiration; For the person with cancer, each day is precious and must be faced with courage." I am fortunate to spend my life striving to help patients with cancer, optimizing their quality of life and curing them when possible. My patients, especially young children, have taught me to appreciate my own life ... to not take it for granted. It is our responsibility and goal to devise strategies to maximize the curability or palliation of cancer, while minimizing the adverse effects of treatment. My areas of expertise and special interest include protocol design for patients with lymphomas, sarcomas and childhood cancers, as well as cancer survivorship including the long-term effects of chemotherapy and radiation therapy on normal body tissues and the generation of secondary malignancies. Conditions I Treat - Lymphomas - Sarcomas - Pediatric hematology and oncology (including central nervous system cancer) - Long term side effects of chemotherapy and radiation therapy